Strikingly, the phosphorylation levels of AMPK and PROX1 showed a positive correlation in HCC tissues (Fig. 7a, b), and higher Ser79 phosphorylation levels were associated with a better clinical outcome in HCC patients (Fig. 7c). This evidence concerns the gene PRKAA1 and hepatocellular carcinoma.